Not Yet RecruitingNot Applicable

Turkish USIQ: Validity & Reliability

Turkey (Türkiye)130 participantsStarted 2026-04-15

Plain-language summary

The Urgency, Severity, and Impact Questionnaire (USIQ) assesses urinary urgency independently of incontinence, measuring both symptom severity and its impact on quality of life. While validated in English and Hebrew populations, a Turkish version has not yet been developed. This study aims to adapt USIQ for the Turkish population and evaluate its psychometric properties, providing a standardized, culturally relevant tool for clinical and research use.

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women aged 18-65 years * Able to read and write in Turkish * Diagnosed with overactive bladder (OAB) presenting with urgency (either wet or dry type) * Willing to sign the informed consent form after being informed about the study Exclusion Criteria: * Urinary tract infection symptoms or an active infection diagnosis within the past month * Neurological conditions causing neurogenic bladder such as multiple sclerosis, Parkinson's disease, stroke, or spinal cord injury * Cognitive impairment preventing comprehension and completion of the questionnaires * Post-void residual urine volume (PVR) exceeding 150 mL * History of bladder stones, bladder tumors, or recent major urogenital surgery * Pregnancy or suspected pregnancy

What they're measuring

Urgency, Severity and Impact Questionnaire (USIQ)

Timeframe: At Baseline

Incontinence Impact Questionnaire-Short Form (IIQ-7)

Timeframe: At baseline

Urogenital Distress Inventory-Short Form (UDI-6)

Timeframe: At baseline

International Consultation on Incontinence Modular Questionnaire-Overactive Bladder Quality of Life Questionnaire (ICIQ-OABqol / OAB-q)

Timeframe: At baseline

Trial details

NCT IDNCT07452796

SponsorIzmir Democracy University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-07-15

Contact for this trial

Betül Taşpınar, Prof.Dr.

0 506 680 44 26 betul.taspinar@idu.edu.tr

View on ClinicalTrials.gov More Overactive Bladder trials

Plain-language summary

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Urgency, Severity and Impact Questionnaire (USIQ)

Timeframe: At Baseline

Incontinence Impact Questionnaire-Short Form (IIQ-7)

Timeframe: At baseline

Urogenital Distress Inventory-Short Form (UDI-6)

Timeframe: At baseline

International Consultation on Incontinence Modular Questionnaire-Overactive Bladder Quality of Life Questionnaire (ICIQ-OABqol / OAB-q)

Timeframe: At baseline